The field of longevity has undergone a complete metamorphosis in the last decade. From something that drew polite smiles at cocktail parties, it has become a multi-billion dollar industry, with influencers selling supplements, podcasts marketing expensive interventions, and billionaires declaring they have cracked the code. Amidst this noise, it is time to stop and hear what the scientists themselves have to say. The Buck Institute for Research on Aging, the only research institution in the world dedicated entirely to understanding the biology of aging, held an open panel of its senior researchers under the provocative title: The Science of Longevity, Fact Versus Fiction. One hour of scientists speaking without gloves about what works, what doesn't, and what we must stop paying for.
What the video is about
The panel consists of several lab heads at Buck, each with a different area of expertise: cellular senescence and senolytics, NAD metabolism, epigenetics and partial reprogramming, fasting and caloric restriction, and exercise physiology. They go topic by topic and ask the same question time and again: What is the evidence in humans? At what stage of clinical trial are we? And what is the gap between what works in mice and what will work in humans? They dwell on senolytics, drugs meant to kill zombie cells in the body, and explain that the data in humans is still limited, mostly pilot in nature, and that the distance from success in mice to the FDA is sometimes a decade or more. They touch on NAD and the supplements NMN and NR, separating what has been observed in the lab from the promises in advertisements. They discuss partial reprogramming using Yamanaka factors, the Blue Zones and the growing criticism of their methodology, and what truly has the highest return today, according to existing evidence: quality sleep, structured physical activity, and intermittent fasting at a reasonable intensity. The lecture's uniqueness is not in dramatic scientific novelty, but rather in the cautious academic pause that the Buck Institute allows itself: to talk about what is still unknown, not to promise, and to clearly mark where the line between basic science and clinical application lies.
Why you should watch
In a world of podcasts selling $300-a-month pills and gurus promising to add 15 years to life, there is something refreshing about academia saying out loud "we don't know yet." This is an important lecture for anyone interested in longevity science and confused by the conflicting messages coming from every direction. Instead of another influencer selling his book, here you get a panel of active researchers who work on the basic mechanisms daily and have no financial interest in selling a supplement or protocol. They do not dismiss the field, on the contrary, they believe healthy longevity is an achievable scientific goal. But they demand that evidence be taken seriously, and that long-term clinical trials not be replaced by celebrity anecdotes. If you are just starting your journey, this lecture will save you money, disappointment, and years of chasing false promises. If you are already deep in the field, it will remind you where the studies you may already be inclined to accept as established fact truly stand. In an era where hype and marketing threaten to replace serious biology, the voice of the Buck Institute is precisely the voice of reason this field needs, and it is highly recommended for anyone who wants to read the next news about a miracle supplement or revolutionary treatment with healthy, sober eyes.
Enjoy watching!
💬 תגובות (0)
היו הראשונים להגיב על המאמר.